| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 355/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Pidotimod is a synthetic dipeptide with immunological modulatory activity on both the adaptive and innate immune responses. This compound has been shown to induce dendritic cell maturation and up-regulate the expression of HLA-DR and co-stimulatory molecules CD83 and CD86, which are integral to communication with adaptive immunity cells. Pidotimod has also been shown to stimulate dendritic cells to release pro-inflammatory molecules such as MCP-1 and TNF-α cytokines, and to inhibit thymocyte apoptosis caused by a variety of apoptosis inducing molecules.
Pidotimod is used for the prevention and treatment of respiratory and urinary tract infections in patients with a compromised immune system. It is used along with other mainstream medications to treat and prevent chronic bronchitis, rhinitis, sinusitis, infections of the urinary tract, etc.
| Analysi | Specifications | Result |
| Assay | ≥99% | 99.2% |
| Appearance | White powder | Complies |
| Loss on Drying | ≤1.0% | 0.04% |
| Ash | ≤1.0% | 0.1% |
| As | ≤2.0ppm | <2.0ppm |
| Pb | ≤2.0ppm | <2.0ppm |
| Insoluble impurity content | ≤0.05% | Complies |
| Total Plate Count | ≤1000 cfu/g | Complies |
| Yeast &. Mold | ≤100 cfu/g | Complies |
| E.Coli | Negative | Negative |
| Salmonella | Negative | Negative |
| Conclusion |
Conform USP Standard.
|
|
| Storage condition |
Store in cool & dry place, Keep away from strong light and heat.
|
|
| Shelf life |
2 years when properly stored.
|
|
){kind=link}